Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2015 May 28;125(22):3411-9.
doi: 10.1182/blood-2015-01-621680. Epub 2015 Mar 26.

Energy balance and fitness in adult survivors of childhood acute lymphoblastic leukemia

Affiliations
Clinical Trial

Energy balance and fitness in adult survivors of childhood acute lymphoblastic leukemia

Kirsten K Ness et al. Blood. .

Abstract

There is limited information on body composition, energy balance, and fitness among survivors of childhood acute lymphoblastic leukemia (ALL), especially those treated without cranial radiation therapy (CRT). This analysis compares these metrics among 365 ALL survivors with a mean age of 28.6 ± 5.9 years (149 treated with and 216 without CRT) and 365 age-, sex-, and race-matched peers. We also report risk factors for outcomes among survivors treated without CRT. Male survivors not exposed to CRT had abnormal body composition when compared with peers (% body fat, 26.2 ± 8.2 vs 22.7 ± 7.1). Survivors without CRT had similar energy balance but had significantly impaired quadriceps strength (-21.9 ± 6.0 Newton-meters [Nm]/kg, 60°/s) and endurance (-11.4 ± 4.6 Nm/kg, 300°/s), exercise capacity (-2.0 ± 2.1 ml/kg per minute), low-back and hamstring flexibility (-4.7 ± 1.6 cm), and dorsiflexion range of motion (-3.1 ± 0.9°) and higher modified total neuropathy scores (+1.6 ± 1.1) than peers. Cumulative asparaginase dose ≥120,000 IU/m(2) was associated with impaired flexibility, vincristine dose ≥39 mg/m(2) with peripheral neuropathy, glucocorticoid (prednisone equivalent) dose ≥8000 mg/m(2) with hand weakness, and intrathecal methotrexate dose ≥225 mg with dorsiflexion weakness. Physical inactivity was associated with hand weakness and decreased exercise capacity. Smoking was associated with peripheral neuropathy. Elimination of CRT from ALL therapy has improved, but not eliminated, body-composition outcomes. Survivors remain at risk for impaired fitness.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Percentages (and 95% confidence intervals) of ALL survivors whose performance on fitness measures is 1.5 SD lower (or higher*) than age and sex-specific comparison-group values.# Low-back and hamstring flexibility was measured with the sit and reach test. Peripheral sensation was measured with the mTNS. Strength in the knee extensors and dorsiflexors was evaluated with isokinetic dynamometry at 60°/s. Muscular endurance was evaluated with isokinetic dynamometry at 300°/s in the quadriceps and 90°/s in the dorsiflexors. DBP, diastolic blood pressure; SBP, systolic blood pressure. #The expected percentage in the population is 6.7%.

Comment in

References

    1. Pui CH, Campana D, Pei D, et al. Treating childhood acute lymphoblastic leukemia without cranial irradiation. N Engl J Med. 2009;360(26):2730–2741. - PMC - PubMed
    1. Howlader N, Noone A, Krapcho M, et al. SEER Cancer Statistics Review (CSR) 1975-2011. http://seer.cancer.gov/csr/1975_2011/. Accessed April 30, 2014.
    1. Wilson CL, Stratton K, Leisenring WL, et al. Decline in physical activity level in the Childhood Cancer Survivor Study cohort. Cancer Epidemiol Biomarkers Prev. 2014;23(8):1619–1627. - PMC - PubMed
    1. Garmey EG, Liu Q, Sklar CA, et al. Longitudinal changes in obesity and body mass index among adult survivors of childhood acute lymphoblastic leukemia: a report from the Childhood Cancer Survivor Study. J Clin Oncol. 2008;26(28):4639–4645. - PMC - PubMed
    1. Järvelä LS, Niinikoski H, Lähteenmäki PM, et al. Physical activity and fitness in adolescent and young adult long-term survivors of childhood acute lymphoblastic leukaemia. J Cancer Surviv. 2010;4(4):339–345. - PubMed

Publication types